These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15050189)

  • 21. Lipid treatment assessment project II in Thailand (LTAP-II Thailand).
    Nitiyanant W; Sritara P; Deerochanawong C; Ngarmukos P; Koanantakul B
    J Med Assoc Thai; 2008 Jun; 91(6):836-45. PubMed ID: 18697382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).
    Bourgault C; Davignon J; Fodor G; Gagné C; Gaudet D; Genest J; Lavoie MA; Leiter L; McPherson R; Sénécal M; Marentette M; Sebaldt RJ
    Can J Cardiol; 2005 Nov; 21(13):1187-93. PubMed ID: 16308595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
    Soubrier M; Zerkak D; Dougados M
    J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia.
    van der Net JB; Isaacs A; Dallinga-Thie GM; Kastelein JJ; Defesche JC; Steyerberg EW; Sijbrands EJ
    J Hypertens; 2008 Mar; 26(3):462-7. PubMed ID: 18300856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia.
    Guardamagna O; Restagno G; Rolfo E; Pederiva C; Martini S; Abello F; Baracco V; Pisciotta L; Pino E; Calandra S; Bertolini S
    J Pediatr; 2009 Aug; 155(2):199-204.e2. PubMed ID: 19446849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral arterial disease in patients with stages IV and V chronic renal failure.
    Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A
    Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress testing response in women heterozygous for familial hypercholesterolemia.
    Kolovou GD; Damaskos DS; Anagnostopoulou KK; Salpea KD; Dritsas A; Giannakopoulou V; Vasiliadis IK; Cokkinos DV
    Int J Cardiol; 2007 Oct; 122(1):96-7. PubMed ID: 17239976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences between clinical trial efficacy and real-world effectiveness.
    Davidson MH
    Am J Manag Care; 2006 Nov; 12(15 Suppl):S405-11. PubMed ID: 17112328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achievement of English National Service Framework lipid-lowering goals: pooled data from recent comparative treatment trials of statins at starting doses.
    Hobbs FD; Southworth H
    Int J Clin Pract; 2005 Oct; 59(10):1171-7. PubMed ID: 16178985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
    Fruchart JC; Sacks F; Hermans MP; Assmann G; Brown WV; Ceska R; Chapman MJ; Dodson PM; Fioretto P; Ginsberg HN; Kadowaki T; Lablanche JM; Marx N; Plutzky J; Reiner Z; Rosenson RS; Staels B; Stock JK; Sy R; Wanner C; Zambon A; Zimmet P
    Am J Cardiol; 2008 Nov; 102(10 Suppl):1K-34K. PubMed ID: 19068318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
    Bild DE; Williams RR; Brewer HB; Herd JA; Pearson TA; Stein E
    Am J Cardiol; 1993 Sep; 72(10):1D-5D. PubMed ID: 8105671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Gorter PM; Olijhoek JK; van der Graaf Y; Algra A; Rabelink TJ; Visseren FL;
    Atherosclerosis; 2004 Apr; 173(2):363-9. PubMed ID: 15064114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.